NPR's Julie Rovner reports on efforts on Capitol Hill to develop a "patients' bill of rights," which seems unlikely to be approved this year. Negotiators also are working on a "drug reimportation" bill, which would make it easier to import US made drugs after they've been exported, and sell them at lower prices than drugs intended for the US market. The drug bill's chances of becoming law are unclear. It is attached to a popular agriculture measure, and has a better chance of survival than if it stood alone.
Copyright 2000 NPR
